img

Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

13-Valent Pneumococcal Polysaccharide Conjugate Vaccine report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Hospital and Clinic are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine key manufacturers include Pfizer, Kangtai and Walvax Biotechnology, etc. Pfizer, Kangtai, Walvax Biotechnology are top 3 players and held % sales share in total in 2022.
13-Valent Pneumococcal Polysaccharide Conjugate Vaccine can be divided into Vials and Pre-filled, etc. Vials is the mainstream product in the market, accounting for % sales share globally in 2022.
13-Valent Pneumococcal Polysaccharide Conjugate Vaccine is widely used in various fields, such as Hospital, Clinic and CDC,, etc. Hospital provides greatest supports to the 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine industry development. In 2022, global % sales of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine went into Hospital filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Pfizer
Kangtai
Walvax Biotechnology
Segment by Type
Vials
Pre-filled

Segment by Application


Hospital
Clinic
CDC

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine introduction, etc. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Market Overview
1.1 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Product Overview
1.2 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Market Segment by Type
1.2.1 Vials
1.2.2 Pre-filled
1.3 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Market Size by Type
1.3.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Market Size Overview by Type (2018-2029)
1.3.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Historic Market Size Review by Type (2018-2024)
1.3.3 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Breakdown by Type (2018-2024)
1.4.2 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Breakdown by Type (2018-2024)
1.4.4 Latin America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Breakdown by Type (2018-2024)
2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Market Competition by Company
2.1 Global Top Players by 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales (2018-2024)
2.2 Global Top Players by 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue (2018-2024)
2.3 Global Top Players by 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Price (2018-2024)
2.4 Global Top Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Market Competitive Situation and Trends
2.5.1 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Market
2.8 Key Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Status and Outlook by Region
3.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Historic Market Size by Region
3.2.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales in Volume by Region (2018-2024)
3.2.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales in Value by Region (2018-2024)
3.2.3 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Forecasted Market Size by Region
3.3.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales in Volume by Region (2024-2029)
3.3.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales in Value by Region (2024-2029)
3.3.3 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine by Application
4.1 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 CDC
4.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Market Size by Application
4.2.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Market Size Overview by Application (2018-2029)
4.2.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Historic Market Size Review by Application (2018-2024)
4.2.3 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Breakdown by Application (2018-2024)
4.3.2 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Breakdown by Application (2018-2024)
4.3.4 Latin America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Breakdown by Application (2018-2024)
5 North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine by Country
5.1 North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Historic Market Size by Country
5.1.1 North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales in Volume by Country (2018-2024)
5.1.3 North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales in Value by Country (2018-2024)
5.2 North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Forecasted Market Size by Country
5.2.1 North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales in Volume by Country (2024-2029)
5.2.2 North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales in Value by Country (2024-2029)
6 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine by Country
6.1 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Historic Market Size by Country
6.1.1 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales in Volume by Country (2018-2024)
6.1.3 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales in Value by Country (2018-2024)
6.2 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Forecasted Market Size by Country
6.2.1 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales in Volume by Country (2024-2029)
6.2.2 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales in Value by Country (2024-2029)
7 Asia-Pacific 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine by Region
7.1 Asia-Pacific 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales in Value by Region (2018-2024)
7.2 Asia-Pacific 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales in Value by Region (2024-2029)
8 Latin America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine by Country
8.1 Latin America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Historic Market Size by Country
8.1.1 Latin America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales in Volume by Country (2018-2024)
8.1.3 Latin America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales in Value by Country (2018-2024)
8.2 Latin America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Forecasted Market Size by Country
8.2.1 Latin America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales in Volume by Country (2024-2029)
8.2.2 Latin America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales in Value by Country (2024-2029)
9 Middle East and Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine by Country
9.1 Middle East and Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales in Value by Country (2018-2024)
9.2 Middle East and Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Products Offered
10.1.5 Pfizer Recent Development
10.2 Kangtai
10.2.1 Kangtai Company Information
10.2.2 Kangtai Introduction and Business Overview
10.2.3 Kangtai 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Kangtai 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Products Offered
10.2.5 Kangtai Recent Development
10.3 Walvax Biotechnology
10.3.1 Walvax Biotechnology Company Information
10.3.2 Walvax Biotechnology Introduction and Business Overview
10.3.3 Walvax Biotechnology 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Walvax Biotechnology 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Products Offered
10.3.5 Walvax Biotechnology Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Industrial Chain Analysis
11.4 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Market Dynamics
11.4.1 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Industry Trends
11.4.2 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Market Drivers
11.4.3 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Market Challenges
11.4.4 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Distributors
12.3 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Vials
Table 2. Major Company of Pre-filled
Table 3. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 4. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Type (2018-2024) & (K Units)
Table 5. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share in Volume by Type (2018-2024)
Table 6. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Type (2018-2024) & (US& Million)
Table 7. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Market Share in Value by Type (2018-2024)
Table 8. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Price by Type (2018-2024) & (US$/Unit)
Table 9. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Type (2024-2029) & (K Units)
Table 10. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share in Volume by Type (2024-2029)
Table 11. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Type (2024-2029) & (US$ Million)
Table 12. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share in Value by Type (2024-2029)
Table 13. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Price by Type (2024-2029) & (US$/Unit)
Table 14. North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Type (2018-2024) & (K Units)
Table 15. North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales (K Units) by Type (2018-2024)
Table 17. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales (K Units) by Type (2018-2024)
Table 19. Asia-Pacific 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales (K Units) by Type (2018-2024)
Table 21. Latin America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales (K Units) by Type (2018-2024)
Table 23. Middle East and Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 24. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Company (2018-2024) & (K Units)
Table 25. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Share by Company (2018-2024)
Table 26. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Share by Company (2018-2024)
Table 28. Global Market 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Price by Company (2018-2024) & (US$/Unit)
Table 29. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine as of 2022)
Table 32. Date of Key Manufacturers Enter into 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Market
Table 33. Key Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 36. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Region (2018-2024) & (K Units)
Table 37. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share in Volume by Region (2018-2024)
Table 38. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Region (2018-2024) & (US$ Million)
Table 39. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share in Value by Region (2018-2024)
Table 40. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 41. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Region (2024-2029) & (K Units)
Table 42. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share in Volume by Region (2024-2029)
Table 43. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Region (2024-2029) & (US$ Million)
Table 44. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share in Value by Region (2024-2029)
Table 45. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 46. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 47. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Application (2018-2024) & (K Units)
Table 48. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share in Volume by Application (2018-2024)
Table 49. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 50. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share in Value by Application (2018-2024)
Table 51. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Price by Application (2018-2024) & (US$/Unit)
Table 52. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Application (2024-2029) & (K Units)
Table 53. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share in Volume by Application (2024-2029)
Table 54. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Application (2024-2029) & (US$ Million)
Table 55. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share in Value by Application (2024-2029)
Table 56. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Price by Application (2024-2029) & (US$/Unit)
Table 57. North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Application (2018-2024) (K Units)
Table 58. North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Application (2018-2024) (K Units)
Table 60. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Application (2018-2024) (K Units)
Table 62. Asia-Pacific 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Application (2018-2024) (K Units)
Table 64. Latin America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Application (2018-2024) (K Units)
Table 66. Middle East and Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 67. North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Country (2018-2024) & (K Units)
Table 68. North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 69. North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 70. North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share in Value by Country (2018-2024)
Table 71. North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Country (2024-2029) & (K Units)
Table 72. North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share in Volume by Country (2024-2029)
Table 73. North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Country (2024-2029) & (US$ Million)
Table 74. North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share in Value by Country (2024-2029)
Table 75. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Country (2018-2024) & (K Units)
Table 76. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share in Value by Country (2018-2024)
Table 79. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Country (2024-2029) & (K Units)
Table 80. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share in Volume by Country (2024-2029)
Table 81. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Country (2024-2029) & (US$ Million)
Table 82. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share in Value by Country (2024-2029)
Table 83. Asia-Pacific 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Region (2018-2024) & (K Units)
Table 84. Asia-Pacific 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Region (2024-2029) & (K Units)
Table 88. Asia-Pacific 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share in Volume by Region (2024-2029)
Table 89. Asia-Pacific 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Region (2024-2029) & (US$ Million)
Table 90. Asia-Pacific 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share in Value by Region (2024-2029)
Table 91. Latin America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Country (2018-2024) & (K Units)
Table 92. Latin America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Country (2024-2029) & (K Units)
Table 96. Latin America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share in Volume by Country (2024-2029)
Table 97. Latin America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Country (2024-2029) & (US$ Million)
Table 98. Latin America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share in Value by Country (2024-2029)
Table 99. Middle East and Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Country (2018-2024) & (K Units)
Table 100. Middle East and Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Country (2024-2029) & (K Units)
Table 104. Middle East and Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share in Volume by Country (2024-2029)
Table 105. Middle East and Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Country (2024-2029) & (US$ Million)
Table 106. Middle East and Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share in Value by Country (2024-2029)
Table 107. Pfizer Company Information
Table 108. Pfizer Introduction and Business Overview
Table 109. Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Product
Table 111. Pfizer Recent Development
Table 112. Kangtai Company Information
Table 113. Kangtai Introduction and Business Overview
Table 114. Kangtai 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. Kangtai 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Product
Table 116. Kangtai Recent Development
Table 117. Walvax Biotechnology Company Information
Table 118. Walvax Biotechnology Introduction and Business Overview
Table 119. Walvax Biotechnology 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. Walvax Biotechnology 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Product
Table 121. Walvax Biotechnology Recent Development
Table 122. Key Raw Materials Lists
Table 123. Raw Materials Key Suppliers Lists
Table 124. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Market Trends
Table 125. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Market Drivers
Table 126. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Market Challenges
Table 127. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Market Restraints
Table 128. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Distributors List
Table 129. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Downstream Customers
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Product Picture
Figure 2. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of Vials
Figure 6. Global Vials Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Pre-filled
Figure 8. Global Pre-filled Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Type (2018-2029) & (US$ Million)
Figure 10. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share by Type in 2022 & 2029
Figure 11. North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share in Volume by Type in 2022
Figure 12. North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share in Value by Type in 2022
Figure 13. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share in Volume by Type in 2022
Figure 14. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share in Value by Type in 2022
Figure 17. Latin America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share in Volume by Type in 2022
Figure 18. Latin America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue in 2022
Figure 23. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Hospital
Figure 25. Global Hospital Sales YoY Growth (2018-2029) & (K Units)
Figure 26. Product Picture of Clinic
Figure 27. Global Clinic Sales YoY Growth (2018-2029) & (K Units)
Figure 28. Product Picture of CDC
Figure 29. Global CDC Sales YoY Growth (2018-2029) & (K Units)
Figure 30. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Application (2018-2029) & (US$ Million)
Figure 31. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share by Application in 2022 & 2029
Figure 32. North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share in Volume by Application in 2022
Figure 33. North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share in Value by Application in 2022
Figure 34. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share in Volume by Application in 2022
Figure 35. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share in Value by Application in 2022
Figure 38. Latin America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share in Volume by Application in 2022
Figure 39. Latin America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Manufacturing Cost Structure
Figure 43. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries